71 related articles for article (PubMed ID: 27815549)
1. Pregnant women's attitudes about topical microbicides for the prevention and treatment of bacterial vaginosis during pregnancy.
Catallozzi M; Fraiz LD; Hargreaves KM; Zimet GD; Stanberry LR; Ratner AJ; Gelber SE; Rosenthal SL
Int J STD AIDS; 2017 Aug; 28(9):881-886. PubMed ID: 27815549
[TBL] [Abstract][Full Text] [Related]
2. Preferred characteristics of vaginal microbicides in women with bacterial vaginosis.
Cook RL; Downs JS; Marrazzo J; Switzer GE; Tanriover O; Wiesenfeld H; Murray PJ; Hillier SL
J Womens Health (Larchmt); 2009 Aug; 18(8):1163-7. PubMed ID: 19630538
[TBL] [Abstract][Full Text] [Related]
3. Microbicides: information, beliefs, and preferences for insertion.
Auslander BA; Perfect MM; Breitkopf DM; Succop PA; Rosenthal SL
J Womens Health (Larchmt); 2007 Dec; 16(10):1458-67. PubMed ID: 18062761
[TBL] [Abstract][Full Text] [Related]
4. Women's interest in vaginal microbicides.
Darroch JE; Frost JJ
Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
[TBL] [Abstract][Full Text] [Related]
5. Attitudes towards microbicide use for bacterial vaginosis in pregnancy.
Catallozzi M; Williams CY; Zimet GD; Hargreaves KM; Gelber SE; Ratner AJ; Stanberry LR; Rosenthal SL
Sex Health; 2014 Sep; 11(4):305-12. PubMed ID: 25140927
[TBL] [Abstract][Full Text] [Related]
6. Pregnant young women's attitudes about microbicides: the anticipated influence of the grandmother and father of the baby on microbicide use.
Francis JKR; Fraiz LD; Catallozzi M; deRoche AM; Mauro C; Rosenthal SL
Sex Health; 2017 Nov; 14(6):581-583. PubMed ID: 28514991
[TBL] [Abstract][Full Text] [Related]
7. Health practices and vaginal microbicide acceptability among urban black women.
Reiff M; Wade C; Chao MT; Kronenberg F; Cushman LF
J Womens Health (Larchmt); 2008 Oct; 17(8):1345-51. PubMed ID: 18788991
[TBL] [Abstract][Full Text] [Related]
8. Bacterial vaginosis in pregnancy: diagnosis and treatment practices of physicians in San Diego, California, 1999.
Callahan DB; Weinberg M; Gunn RA
Sex Transm Dis; 2003 Aug; 30(8):645-9. PubMed ID: 12897687
[TBL] [Abstract][Full Text] [Related]
9. Microbicide preference among young women in California.
Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
[TBL] [Abstract][Full Text] [Related]
10. Evidence of African-American women's frustrations with chronic recurrent bacterial vaginosis.
Payne SC; Cromer PR; Stanek MK; Palmer AA
J Am Acad Nurse Pract; 2010 Feb; 22(2):101-8. PubMed ID: 20132368
[TBL] [Abstract][Full Text] [Related]
11. Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis.
Marrazzo JM; Cook RL; Wiesenfeld HC; Murray PJ; Busse B; Krohn M; Hillier SL
J Womens Health (Larchmt); 2006 Nov; 15(9):1053-60. PubMed ID: 17125424
[TBL] [Abstract][Full Text] [Related]
12. Treatment considerations for bacterial vaginosis and the risk of recurrence.
Chen JY; Tian H; Beigi RH
J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
[TBL] [Abstract][Full Text] [Related]
13. Associations between intravaginal practices and bacterial vaginosis in Kenyan female sex workers without symptoms of vaginal infections.
Hassan WM; Lavreys L; Chohan V; Richardson BA; Mandaliya K; Ndinya-Achola JO; Kiarie J; Jaoko W; Holmes KK; McClelland RS
Sex Transm Dis; 2007 Jun; 34(6):384-8. PubMed ID: 17065846
[TBL] [Abstract][Full Text] [Related]
14. Bacterial vaginosis during pregnancy. Should we screen for and treat it?
Einarson A; Koren G
Can Fam Physician; 2002 May; 48():877-8. PubMed ID: 12053630
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicide.
Harwell JI; Moench T; Mayer KH; Chapman S; Rodriguez I; Cu-Uvin S
J Womens Health (Larchmt); 2003 Apr; 12(3):255-9. PubMed ID: 12804356
[TBL] [Abstract][Full Text] [Related]
16. High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study.
Alcaide ML; Rodriguez VJ; Brown MR; Pallikkuth S; Arheart K; Martinez O; Roach M; Fichorova RN; Jones DL; Pahwa S; Fischl MA
AIDS Res Hum Retroviruses; 2017 Apr; 33(4):309-317. PubMed ID: 27897054
[TBL] [Abstract][Full Text] [Related]
17. Bacterial vaginosis and intravaginal practices: association with HIV.
Mbizvo ME; Musya SE; Stray-Pedersen B; Chirenje Z; Hussain A
Cent Afr J Med; 2004; 50(5-6):41-6. PubMed ID: 15881309
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and pregnancy outcomes of pregnant women asymptomatic for bacterial vaginosis.
Nelson DB; Bellamy S; Clothier BA; Macones GA; Nachamkin I; Ruffin A; Allen-Taylor L; Friedenberg FK
Matern Child Health J; 2008 Mar; 12(2):216-22. PubMed ID: 17546484
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health.
Koumans EH; Sternberg M; Bruce C; McQuillan G; Kendrick J; Sutton M; Markowitz LE
Sex Transm Dis; 2007 Nov; 34(11):864-9. PubMed ID: 17621244
[TBL] [Abstract][Full Text] [Related]
20. Determinants of intravaginal practices among HIV-infected women in Zambia using conjoint analysis.
Alcaide ML; Cook R; Chisembele M; Malupande E; Jones DL
Int J STD AIDS; 2016 May; 27(6):453-61. PubMed ID: 25957322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
